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Abstract
Jun is a highly conserved member of the multimeric activator protein 1 transcription factor complex and plays an important
role in human cancer where it is known to be critical for proliferation, cell cycle regulation, differentiation, and cell death. All
of these biological functions are also crucial for embryonic development. Although all Jun null mouse embryos die at mid-
gestation with persistent truncus arteriosus, a severe cardiac outflow tract defect also seen in human congenital heart
disease, the developmental mechanisms are poorly understood. Here we show that murine Jun is expressed in a restricted
pattern in several cell populations important for cardiovascular development, including the second heart field, pharyngeal
endoderm, outflow tract and atrioventricular endocardial cushions and post-migratory neural crest derivatives. Several
genes, including Isl1, molecularly mark the second heart field. Isl1 lineages include myocardium, smooth muscle, neural
crest, endocardium, and endothelium. We demonstrate that conditional knockout mouse embryos lacking Jun in Isl1-
expressing progenitors display ventricular septal defects, double outlet right ventricle, semilunar valve hyperplasia and
aortic arch artery patterning defects. In contrast, we show that conditional deletion of Jun in Tie2-expressing endothelial
and endocardial precursors does not result in aortic arch artery patterning defects or embryonic death, but does result in
ventricular septal defects and a low incidence of semilunar valve defects, atrioventricular valve defects and double outlet
right ventricle. Our results demonstrate that Jun is required in Isl1-expressing progenitors and, to a lesser extent, in
endothelial cells and endothelial-derived endocardium for cardiovascular development but is dispensable in both cell types
for embryonic survival. These data provide a cellular framework for understanding the role of Jun in the pathogenesis of
congenital heart disease.
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Introduction
Jun (a.k.a. c-Jun) is a highly conserved member of the
multimeric activator protein 1 (AP-1) transcription factor complex
[1]. The AP-1 protein complexes are a heterogeneous group of
transcriptionally active dimers and include members of the Jun
family (Jun, Jund, Junb), Fos family (c-Fos, Fosb, Fosl1, Fosl2) and
other transcription factor families such as ATF and Maf [2].
Several Jun mutant mice have been generated to study AP-1
function. While Jun heterozygous mice are normal [3], all Jun null
embryos die between E12.5 and E14.5 with persistent truncus
arteriosus (PTA) [3,4,5]. PTA is a severe developmental cardiac
abnormality seen in many patients as an isolated finding or as part
of a syndrome such as DiGeorge/22q11 deletion syndrome. Jun
proteins can form homo- or heterodimers to differentially regulate
transcription [1]. Examination of the promiscuity of these dimer
protein-protein interactions has revealed that as part of a DNA-
binding complex, Jun is critical for multiple biological processes
including cell proliferation, apoptosis, cell cycle progression and
differentiation [6,7,8,9]. Although these cellular phenomena are
critical for mammalian development and for diseases such as
cancer, data regarding the role of Jun during embryogenesis is
limited.
The cardiac outflow tract (OFT) incorporates the lineages of
multiple cardiac progenitors and its development is dependent
upon the complex interaction of several cell types. Neural crest
(NC) cells migrate from the dorsal neural tube to the developing
aorticopulmonary septation complex to mediate septation of the
truncus arteriosus into the main pulmonary artery and aorta [10].
These NC cells contribute to the OFT endocardial cushion
mesenchyme which is also comprised of endothelial-derived
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endocardial cells [11]. Second heart field (SHF) progenitors
contribute to the OFT myocardium and smooth muscle [12,13]
while endothelial progenitors give rise to the mature endothelial
cells and semilunar valves of the OFT [14,15]. Defects seen in Jun
null embryos are striking and may be mediated by Jun function in
one or more of these cell populations involved in OFT
development. Here we show that murine Jun is expressed in a
restricted pattern in several cell populations important for
cardiovascular development, including the SHF, pharyngeal
endoderm, OFT endocardial cushions, atrioventricular (AV)
endocardial cushions and post-migratory NC derivatives. Using
tissue-specific conditional deletion studies in mice, we demonstrate
that Jun is required in Isl1-expressing progenitors and, to a lesser
extent, in endothelial cells and endothelial-derived endocardium
for cardiovascular development but is dispensable in both cell
types for embryonic survival.
Results
Jun is Detected during Mid-gestation in Restricted Cell
Populations
Several cell populations are important for normal OFT
development and septation. The 100% incidence of PTA in Jun
null embryos indicates that Jun is clearly required in one or more
of these cell populations. An overview of Jun’s spatial and temporal
expression pattern during embryonic development in the mouse is
lacking in the literature, particularly prior to E14.5. In limited
expression analyses by in situ hybridization and Northern blot, it
has been reported that Jun mRNA is expressed in the developing
heart, cartilage, gut, central nervous system, lung, kidney, adrenal
gland and placenta of the developing mouse [16,17,18,19,20]. To
determine the specific cell populations in which Jun might be
functioning to regulate cardiac morphogenesis, we examined the
expression of Jun by in situ hybridization and immunohistochem-
istry at several stages of embryonic development between E8.5 and
E15.5. Our Jun expression analysis revealed expression in multiple
tissues important for heart development and aortic arch artery
remodeling. At E8.5, Jun was expressed in the pharyngeal
endoderm, dorsal aortae, common atrial chamber, endocardial
cushions and in regions populated by SHF mesoderm (Fig. 1A).
The anterior SHF expression was stronger than the posterior SHF
(Fig. 1A). The expression of Jun in the SHF was also evident at
E9.5 by whole mount in situ hybridization (Fig. 1B, C). This is
consistent with our previous observation of Jun expression in SHF-
derived OFT myocardium [21]. At E9.5, Jun was expressed in the
otic vesicle, telencephalon, somites, and aortic arch arteries
(Fig. 1B, C). The expression in the telencephalon, somites and
pharyngeal arches is consistent with publically available in situ
hybridization data at E11 (http://goo.gl/DoJro) [22]. At E10.5,
Jun was highly expressed in the OFT endocardial cushions, AV
endocardial cushions and cranial nerve IX (Fig. 1D). The high
levels of Jun expression in the OFT endocardial cushions persists
until E11.5 (Fig. 1E), where expression in pericardium (Fig. 1E)
and dorsal root ganglia (data not shown) was also evident. At
E15.5, Jun was broadly expressed in the myocardium and both the
semilunar and AV valves (Fig. S1).
Conditional Deletion of Jun in Isl1-expressing Progenitors
Results in Severe Cardiovascular Malformations
Jun is expressed in the SHF (Fig. 1) and SHF-derived
myocardium (Fig. S1) [21]. The SHF comprises a specialized
subset of cardiac progenitor cells derived from early splanchnic
mesoderm [13]. These progenitors are marked by the expression
of genes such as Isl1 [13,23,24] and play a critical role in the
development of the right ventricle and OFT. To determine if Jun
is expressed in Isl1-positive cells, we examined the expression of
Jun and Isl1 at E8.5 using immunohistochemistry. Our analysis
using confocal microscopy revealed co-localization of Jun and Isl1
in the anterior SHF mesoderm (Fig. 2A, C–F) and pharyngeal
endoderm (Fig. 2A, B).
To determine if Jun is required in Isl1-expressing progenitors,
we performed a conditional deletion of Jun using Isl1Cre/+ knock-in
mice [25,26]. There are several mutant mice expressing Cre
recombinase in Isl1–expressing lineages [25,26,27,28]. To avoid
the variable Cre activity observed with the Isl1-IRES-Cre mice
(Isl1tm1(cre)Tmj) [25,27], we utilized the Isl1Cre/+ knock-in mice [25]
which have been extensively characterized and shown to drive Cre
recombinase expression as early as E8-8.5 [25,26]. Jun conditional
knockout mice (Junflox/flox) [7] have been validated through tissue-
specific deletion in liver [7,29], neuroepithelial cells [30],
keratinocytes [31,32] and notochord and sclerotome [33]. To
determine if Jun was deleted in the Isl1 lineage, we performed Jun
immunostaining of E10.5 Isl1Cre/+; Junflox/flox; mT/mG and control
embryos. Cre-mediated recombination in mT/mG embryos [34]
indelibly marks Isl1-derived progenitors with GFP expression.
Confocal microscopy of Isl1Cre/+; Junflox/flox and control embry-
onic sections revealed that Jun was efficiently deleted in derivatives
of Isl1-expressing progenitors residing in the OFT (Fig. 3).
Isl1Cre/+; Junflox/flox embryos were present at the expected
Mendelian ratios (E14.5-P0, n = 23, 100% of predicted; Table 1)
and thus survived longer than Jun null embryos [3,4,5]. This
suggests that Jun function in Isl1-expressing cells is not responsible
for the embryonic mortality seen in Jun null embryos and supports
the hypothesis of Hilberg and Eferl et al. that the embryonic death
in Jun nulls is attributable to impaired hepatogenesis [3,5] rather
to the cardiac defects. We examined E14.5 to P0 Isl1Cre/+; Junflox/
flox and control embryos for cardiac defects. Upon careful
examination, we found that 32% of Isl1Cre/+; Junflox/flox condi-
tional mutant embryos (n = 22) showed aortic arch artery
remodeling defects (Fig. 4B, B9; Table 2). These defects included
interrupted aortic arch (IAA) type B, hypoplasia of the B segment
of the aortic arch and aberrant retro-esophageal right subclavian
artery. OFT defects were observed in 88% of conditional mutant
embryos (n = 8) and included ventricular septal defect (VSD),
double outlet right ventricle, and semilunar valve hyperplasia
(Fig. 4F, K–N; Table 2). Although there is some evidence that Isl1
progenitors may contribute to the mature AV valves [35], we
observed very few GFP-expressing cells derived from Isl1-
expressing progenitors cells in the developing AV cushions
(Fig. 3A, F). Consistent with this observation, we did not observe
any AV valve defects in Isl1Cre/+; Junflox/flox embryos (Fig. 4G, H;
Table 2).
Because Isl1Cre/+ is a loss-of-function allele [25], we looked for
evidence of a genetic interaction between Isl1 and Jun. Neither
Isl1+/2 nor Isl1Cre/+ mice have discernible cardiac defects
[23,25,36], thus heterozygosity of Isl1 from the Cre knock-in
could not account for the phenotype in Isl1Cre/+; Junflox/flox
mutants. We observed a single Isl1Cre/+; Junflox/+ embryo (1 of 22)
with IAA type B. No other OFT or aortic arch abnormalities were
noted among Isl1Cre/+; Junflox/+ embryos. While this suggests a
subtle genetic interaction, it does not account for the significantly
higher incidence of defects observed in Isl1Cre/+; Junflox/flox
embryos.
Given Jun’s role in proliferation and apoptosis [6,7], we
investigated whether an alteration in one or both of these cellular
processes may contribute to the OFT defects observed in Jun
mutant mice. Using phospho-histone H3 (pHH3) and TUNEL as
markers of cell proliferation and apoptosis, we could not detect any
Jun Is Required in Isl1 Progenitors
PLOS ONE | www.plosone.org 2 February 2013 | Volume 8 | Issue 2 | e57032
statistically significant differences in the percent of pHH3- or
TUNEL-positive cells in serial sections of the OFT of E10.5
Isl1Cre/+; Junflox/flox, Isl1Cre/+; Junflox/2 and control littermates
(Fig. 5A–E). Although the differences were not statistically
significant, there was a trend toward a decrease in proliferating
cells and an increase in apoptosis in the OFT of mutant embryos.
These findings suggest that the observed OFT defects may not be
solely the result of altered proliferation or apoptosis, but raises the
possibility that in combination, these alterations could contribute
to the phenotype.
Endothelial progenitors, contributing to the developing OFT
endocardial cushion mesenchyme, and cardiac NC cells play an
important role in the development of the OFT [10,11,14,15]. We
used NFATc1 as an endocardial marker [14,37] and Tfap2a
(a.k.a. AP-2a) as a marker of migrating NC cells (and ectoderm)
[36,38] to determine if conditional deletion of Jun in Isl1-
expressing progenitors affected the developing endocardium or
NC cells. We could not detect any significant differences in
NFATc1 or Tfap2a expression in E10.5 Isl1Cre/+; Junflox/2
embryos compared with control littermates (Fig. 5F–I). These
findings suggest that the defects observed in Isl1 conditional Jun
mutant embryos are not attributable to a failure of endocardial
formation or cardiac NC migration.
Jun is Required in the Endocardium and Endothelial
Progenitors for Valve and Ventricular Septum Formation
but not for Aortic Arch Artery Remodeling
Although Isl1-expressing progenitors populate the SHF meso-
derm, Isl1 lineages also include other cell populations such as the
endocardium and scattered endothelial cells in the aortic arch
arteries [13,23,24,26,39]. Endothelial cells, giving rise to the
endocardium, undergo an epithelial-to-mesenchymal transforma-
tion to contribute to the OFT cushion mesenchymal tissue during
OFT septation [11]. The endocardial cushions subsequently give
rise to the valves of the mature heart [14,15]. Our finding that Jun
was strongly expressed in the OFT endocardial cushion mesen-
chyme (Fig. 1D, E) together with the prominent endocardial
cushions noted in Jun null embryos [5] suggests that Jun may be
required in the endothelial progenitors giving rise to endocardial
cushion mesenchyme. Hence, we performed fate-mapping studies
of endothelial cells in Jun mutant embryos. Endothelial cells and
endothelial-derived endocardium were marked with ß-galactosi-
dase or GFP expression by crossing transgenic Tie2-Cre mice with
R26R or mT/mG Cre reporter mice [34,40,41]. Tie2-Cre mice
have been extensively characterized and shown to drive expression
specifically in the embryonic endothelium and endocardium as
early as E7.5 [41]. In global Jun nulls at E10.5 (Fig. 6D, E), and in
endothelial-specific conditional mutants at E15.5 (Fig. 6F), we
observed the contribution of Tie2-expressing endothelial progen-
itors to the endothelial cushion mesenchyme and endothelial lining
of the truncus arteriosus and aortic sac and to the semilunar valves
in a pattern similar to control embryos (Fig. 6A–C). Although
these fate mapping experiments suggest that Jun is not required in
Tie2-expressing endothelial progenitors, it remains possible that
the loss of Jun in the endocardium results in a functional defect
resulting in cardiac defects or aortic arch artery remodeling
defects.
To determine if Jun was required for OFT development and
aortic arch artery remodeling, we performed a conditional deletion
of Jun in endothelium and endothelial-derived endocardium by
crossing Junflox/flox mice with transgenic Tie2-Cre mice. To ensure
that Tie2-Cre was efficiently deleting Jun in endothelial progenitors
we performed co-immunostaining for Jun, the endothelial marker,
CD31 (Pecam1) and the smooth muscle cell marker, a-smooth
Figure 1. Jun is expressed in cell populations known to contribute to cardiogenesis. (A) Transverse sections along the full anteroposterior
axis showing Jun immunostaining (green) in the pharyngeal endoderm (pe), SHF mesoderm (*), OFT cushions (open arrowhead), AV cushions (closed
arrowhead), dorsal aortae (DAo) and common atrial chamber (CA). (B, C) Whole mount in situ hybridization of Jun expression in the SHF (arrowhead),
somites (S), otic vesicle (ov) and telencephalon (T). Inset is a higher power image of the area shown in the black box in panel B showing Jun
expression in aortic arch arteries 3, 4 and 6. Parasagittal (D) and transverse (E) sections showing Jun expression in endocardial cushions, and cranial
nerve IX. A, atrium; AoS, aortic sac; AVC, atrioventricular cushion; bc, bulbus cordis; F, foregut; LV, left ventricle; OFTC, outflow tract cushion p,
pericardium; RV, right ventricle; V, ventricle.
doi:10.1371/journal.pone.0057032.g001
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muscle actin (SMA). Confocal microscopy of Junflox/flox and Tie2-
Cre; Junflox/flox embryonic sections revealed that Jun was efficiently
deleted in endothelial cells (Fig. 7J) whereas expression in smooth
muscle cells was unaffected (Fig. 7J, T).
We analyzed embryonic and neonatal Tie2-Cre; Junflox/flox
mutants for a recapitulation of the cardiac phenotype observed
in the Jun null and Isl1 conditional Jun mutant embryos. We
quantified the incidence of embryonic death, aortic arch
remodeling defects, and cardiac defects and found that, similar
to the Isl1Cre/+; Junflox/flox embryos, the endothelial-specific
knockouts of Jun survive until late gestation or even until birth.
Tie2-Cre; Junflox/flox embryos were present at the expected
Mendelian ratios (E15.5-P0; Table 1). We examined E15.5 to
P0 Tie2-Cre; Junflox/flox and control embryos for cardiac defects.
Upon careful examination, we did not observe any Tie2-Cre;
Junflox/flox conditional mutant embryos (n = 10) with aortic arch
artery remodeling defects (Table 2). 43% of conditional mutant
embryos had a perimembranous VSD and 14% had double outlet
right ventricle, mitral or pulmonary valve hyperplasia (Fig. 8A, C;
Table 2). We also noted thinning of the compact myocardium of
the right ventricle (Fig. 8A) in 43% (n= 3/7) of Tie2-Cre; Junflox/flox
embryos. This phenotype is similar to that previously described in
the global Jun null embryos [5]. To determine if these defects were
due to a cell non-autonomous effect on NC cell migration, we
performed Tfap2a immunostaining of Tie2-Cre conditional Jun
mutant and control embryos. We observed a similar pattern of
Tfap2a expression in the developing OFT and pharyngeal arches
in E10.5 Tie2-Cre; Junflox/2 embryos compared with controls
(Fig. 6G–J) suggesting that defects observed in Tie2 conditional Jun
mutant embryos are not attributable to a failure of cardiac NC cell
migration. Thus, Jun is not required in endothelial cells and
endothelial-derived endocardial cushions for aortic arch artery
remodeling or embryonic survival, but is required for the
formation of the ventricular septum, compact myocardium and
to a lesser extent for formation of the OFT and valves.
Discussion
Congenital heart disease (CHD) is the most commonly
occurring major birth defect in humans with an incidence of 6
per 1000 live births [42]. OFT malformations, including PTA,
constitute the largest class of life-threatening CHD. It has been
more than a decade since it was recognized that the global loss of
Jun in mice uniformly results in PTA [5]. Information regarding
Jun expression in cardiac progenitors during critical stages of heart
development has been poorly described and thus it has remained
unclear in what cell populations Jun may regulate transcription.
We show that Jun is expressed in a restricted pattern in several cell
populations including the SHF, pharyngeal endoderm, OFT and
Figure 2. Jun and Isl1 are co-expressed in a subset of cells in the developing outflow tract. (A, D) Transverse sections of an E8.5 wild-type
embryo showing Jun (green) and Isl1 (pink) immunostaining in anterior SHF mesoderm and pharyngeal endoderm. Sections were co-stained with
DAPI to illustrate nuclei. (B, C, E, F) Higher power confocal images of the areas indicated by white boxes in panels A and D. Cell populations co-
expressing Jun and Isl1 are indicated by the open arrowheads. AoS, aortic sac; FG, foregut; H, heart; NT, neural tube; PC, pericardial cavity.
doi:10.1371/journal.pone.0057032.g002
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AV endocardial cushions and post-migratory NC derivatives such
as cranial nerve IX and the dorsal root ganglia.
Although Jun null embryos die with PTA, we did not observe
PTA in conditional Jun mutants. There are at least two
explanations for this finding. There may be functional redundancy
among Jun proteins and/or Jun may be required in other cardiac
progenitors not expressing Isl1. There is evidence to suggest some
degree of functionally redundancy among Jun proteins, such as
Jun, Junb and Jund, during heart development. Jund2/2 mice
have no cardiac defects [43] and Junb2/2 null embryos die at
E8.5-E10 due to multiple defects in extra-embryonic tissues [44].
Wagner et al. have generated mice in which either Junb or Jund is
knocked-in to the Jun locus to test whether Junb or Jund, under the
control of the endogenous Jun regulatory elements, can rescue the
Jun null phenotype [20,45]. While both of these knock-in mice
rescue the mortality at E13 seen in Jun2/2 embryos [20,45], the
rescue of the cardiac defects is not as straightforward. JunJunb/Junb
embryos survive to E18.5 in Mendelian ratios but continue to have
PTA (similar to Jun2/2 embryos [20]) and VSDs. The same
authors then tested whether overexpression of Junb, with Junb
transgenic mice under the control of human ubiquitin C promoter
[46] were able to rescue the Jun null phenotype. Junb-Tg; Jun2/2
embryos are born with no cardiac defects demonstrating
redundancy that is dependent on gene dosage [20]. JunJund/Jund
embryos survive to E18.5 in Mendelian ratios but also display
PTA similar to Jun2/2 embryos [45], suggesting that Jund is not
functionally redundant for Jun during cardiac development. The
rescue of embryonic lethality but not heart defects indicates that
different developmental processes have different sensitivities to Jun
dosage. It is unclear whether Jund overexpression can rescue the
cardiac defects see in Jun null embryos. Future studies to test
whether decreasing the dosage of Jund or Junb will uncover
functional redundancy during heart development may include the
analysis of heart defects in Isl1Cre/+; Junflox/flox; Junb+/2 or Isl1Cre/
+; Junflox/flox; Jund+/2 mutants.
Jun transcriptional activity is dependent on Jun N-terminal
kinase (JNK) phosphorylation [47,48]. This JNK-dependent Jun
phosphorylation is dispensable for embryonic development,
including for cardiogenesis. Behrens et al. demonstrated this by
generating mice in which the Jun locus was mutated to prevent
JNK phosphorylation (JunAA) [49]. JunAA homozygous mice,
unlike Jun2/2 mice, are born in Mendelian ratios and are healthy
and fertile, without heart defects, as adults. The notion that JNK-
dependent phosphorylation is not essential for heart development
is further supported by the observation that Jnk mutant mice
survive without heart defects [50].
An alternative explanation for the PTA seen in Jun null embryos
but not in the conditional mutants is that Jun may have roles in
multiple cell populations involved in regulating OFT septation.
The proximal portion of the OFT cushions (conus) becomes the
subpulmonary infundibulum and failure of this structure to form
properly results in VSDs. The distal OFT cushions (truncus) gives
rise to the semilunar valves and intrapericardial portions of the
aorta and pulmonary artery. More distally, the dorsal wall of the
aortic sac becomes the aorticopulmonary septum. In humans,
defects in this structure result in an aorticopulmonary window
[51,52]. A failure of septation in both the distal OFT and the
aortic sac-derived portion of the great arteries results in PTA
which usually, but not always [53], is associated with VSDs. The
PTA in Jun null embryos [5] together with our observation of
VSDs in the absence of both PTA and a common truncal valve,
supports a model in which ‘‘conal’’ septation, regulated by Jun in
Isl1-progenitors, is mechanistically separate from both ‘‘truncal’’
and aorticopulmonary septation. Jun may play a role in a non-Isl1-
expressing domain to regulate ‘‘truncal’’ and aorticopulmonary
septation.
Heart development is dependent upon the complex interaction
and contribution of several cell types. There are multiple lines of
evidence supporting the notion that within the early mesoderm,
there is a common cardiovascular progenitor that gives rise to
myocardial, smooth muscle and endothelial lineages [54]. Within
Figure 3. Jun is efficiently deleted in derivatives of Isl1-expressing cells in the outflow tract. Saggital sections of E10.5 Isl1Cre/+; mT/mG;
Junflox/+ (A) and Isl1Cre/+; mT/mG; Junflox/flox (F) embryos co-immunostained with anti-GFP (green) and anti-Jun (red) and analyzed by confocal
microscopy showing nuclear Jun expression. Isl1Cre/+-expressing progenitors were marked with GFP expression using the mT/mG double-fluorescent
Cre reporter mice. Sections were co-stained with DAPI to illustrate nuclei. (B–E, G–J) Higher power images of the areas indicated by white boxes in
panels A, F. Jun is efficiently deleted in derivatives of Isl1-expressing progenitors located in the OFT (arrowheads) whereas AV cushion cells (arrows),
not derived from Isl1-expressing progenitors, express Jun in both control (E) and mutant embryos (J). A, atrium; AoS, aortic sac; LV, left ventricle. Scale
bar: 100 mm.
doi:10.1371/journal.pone.0057032.g003
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the splanchnic mesoderm, the SHF, a group of cardiovascular
precursors destined to give rise to the right ventricle and OFT, is
molecularly marked by the expression of Tbx1, a Mef2c regulatory
module, and by Isl1 [13,23,55,56,57]. Data from both murine
models and from humans suggest that ISL1 plays a role in heart
development and possibly human CHD. There is a report of a
diabetic patient who harbors an ISL1 mutation [58], but there
have been none described in patients with CHD. Despite this,
there is evidence to suggest that common ISL1 single nucleotide
polymorphisms (SNPs) are associated with human CHD [59]. It
remains to be determined if these SNPs are causative or if they are
linked to an associated causative locus. The current study provides
data to support a possible role for JUN in ISL1 progenitors and
thus adds to the likelihood that this association may be causative.
Multipotent Isl1-positive progenitors, when isolated and cultured
from either mouse or human embryonic hearts, are capable of
differentiating into each of these three lineages [24,60]. This has
also been demonstrated using a potentially overlapping population
of Nkx2.5-positive progenitor cells [61]. This ex vivo data is
consistent with in vivo fate-mapping studies, using an Isl1 inducible
Cre, showing the contribution of Isl1 derivatives to the same three
lineages [28]. Recent evidence suggests that some Isl1-expressing
Figure 4. Isl1-specific deletion of Jun results in cardiovascular defects. Compared to control embryos (A, A’, C–E, I–L), the loss of Jun in Isl1-
expressing precursors results in IAA (B, B’), VSD (arrowhead, E), and enlarged and hyperplastic pulmonary valve leaflets (arrowhead, O). The
atrioventricular valves are unaffected (C, D, F, G). Ao, aorta; CA, carotid artery; DA, ductus arteriosus; DAo, descending aorta; LA, left atrium; lv, left
ventricle; MV, mitral valve; PA, pulmonary artery; RA, right atrium; rv, right ventricle; SCA, subclavian artery; TV, tricuspid valve.
doi:10.1371/journal.pone.0057032.g004
Table 1. Summary of genotypes for Jun conditional mutants.
Genotype
(E14.5-P0) n (%) Genotype (E15.5-P0) n (%)
Isl1Cre/+; Junflox/+ 23 (25%) Tie2-Cre; Junflox/+ 12 (24%)
Isl1Cre/+; Junflox/flox 23 (25%) Tie2-Cre; Junflox/flox 10 (20%)
Junflox/+ 26 (28%) Junflox/+ 15 (31%)
Junflox/flox 20 (22%) Junflox/flox 12 (24%)
x 2 p = 0.94 x 2 p = 0.92
doi:10.1371/journal.pone.0057032.t001
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progenitor cells may also be of a NC lineage (discussed below)
[62].
Our analysis of mutants lacking Jun in the endothelial lineage
reveals that Jun is required for heart development in some, but not
all, Tie2-derived endothelial cells and endothelial-derived endo-
Table 2. Cardiovascular abnormalities in late gestation Jun conditional mutants.
E14.5–P0 Junflox/+ or Junflox/flox Isl1Cre/+; Junflox/flox Tie2-Cre; Junflox/flox
Aortic arch artery remodeling defects 0% (0/46) 32% (7/22) 0% (0/10)
Ventricular septal defect 0% (0/9) 88% (7/8) 43% (3/7)
Double outlet right ventricle 0% (0/9) 88% (7/8) 14% (1/7)
Mitral valve defect 0% (0/9) 0% (0/8) 14% (1/7)
Tricuspid valve defect 0% (0/9) 0% (0/8) 0% (0/7)
Pulmonary valve defect 0% (0/9) 88% (7/8) 14% (1/7)
Aortic valve defect 0% (0/9) 75% (6/8) 0% (0/7)
doi:10.1371/journal.pone.0057032.t002
Figure 5. Effect of the loss of Jun in Isl1-expressing progenitors on proliferation, apoptosis, cardiac neural crest cells and the
endocardium. Sagittal sections of E10.5 mutant (B, D, G) and control (A, C, F) embryos analyzed by pHH3 and NFATc1 immunostaining and by
TUNEL assay. pHH3 immunostaining (pink) reveals similar proliferation rates in mutant and control OFT cells (A, B). Dotted lines show representative
areas used for cell counting with ImageJ software. TUNEL assay reveals similar numbers of TUNEL-positive (green) OFT cells in mutant and control
embryos (C, D). (E) Quantitative analysis of the percentage of pHH3- and TUNEL-positive OFT cells in serial sections showing a statistically
insignificant trend toward less proliferation and more apoptosis in conditionally deleted embryos at E10.5. Results are expressed as mean 6 SEM of
the percent positive nuclei. The statistical significance of differences between groups was analyzed by the Student’s t-test. (F, G) Expression of the
endocardial marker NFATc1 (pink), is not significantly different between conditional mutant and control embryos. Saggital sections of anti-Tfap2a
immunostained Junflox/2 (H) and Isl1Cre/+; Junflox/2 (I) embryos showing no significant difference in Tfap2a-expressing neural crest cells (arrowheads)
at E10.5. Sections were co-stained with DAPI to illustrate nuclei. A, atrium; AVC, atrioventricular cushion; LV, left ventricle; OFT, outflow tract; OFTC,
outflow tract cushion; SMA, smooth muscle actin.
doi:10.1371/journal.pone.0057032.g005
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Figure 6. Loss of Jun does not alter the fate of Tie2-expressing endothelial derivatives or cardiac neural crest cells in the developing
OFT. Transverse sections of X-gal stained Jun+/2; Tie2-Cre;R26R (A, B) and Jun2/2; Tie2-Cre; R26R (D, E) embryos showing no significant difference in
endothelial derivatives (blue) populating the OFT endocardial cushion mesenchyme (arrowheads) at E10.5. Transverse sections of anti-GFP
immunostained Tie2-Cre; Junflox/+; mT/mG (C) and Tie2-Cre; Junflox/flox; mT/mG (F) embryos showing no significant difference in endothelial derivatives
(green) populating the semilunar valves, heart and blood vessels at E15.5. Transverse sections of anti-Tfap2a immunostained Tie2-Cre; Junflox/+ (G, H)
and Tie2-Cre; Junflox/2 (I, J) embryos showing no significant difference in Tfap2a-expressing neural crest cells at E10.5. Sections were co-stained with
DAPI to illustrate nuclei. Ao, aorta; AoS, aortic sac; LA, left atrium; PA, pulmonary artery; RA, right atrium; TA, truncus arteriosus.
doi:10.1371/journal.pone.0057032.g006
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cardium. The thinning of the compact myocardium of the right
ventricle observed in the Tie2 conditional Jun mutants suggests a
model in which there is signaling from the endocardium to
regulate the differentiation of primitive myocardial epithelium into
compact myocardium. Pathways involved in reciprocal paracrine
signaling between the endocardium and myocardium include
Neuregulin-1, EphrinB2, Notch, Neurofibromin 1, VEGF,
Angiopoietin-1, and Fgf [63,64,65,66,67]. The role of endocardial
Jun in one of these pathways or in a parallel pathway remains to
be determined. It is intriguing that there was no compact zone
thinning of the left ventricle suggesting that endocardial Jun is not
required for the differentiation of all primitive myocardial
epithelium. Our findings of VSDs in both Isl1 and Tie2 conditional
Jun mutants also support this paracrine model although we cannot
conclude from our data whether or not the critical subset of Tie2-
derived cells is descended from Isl1-positive progenitors. Currently
available techniques do not allow us to conditionally delete Jun in
Tie2/Isl1-positive progenitors in vivo while leaving Jun unaltered in
Tie2-positive Isl1-negative progenitors. Thus, it remains to be
tested if Jun is dispensable in the Isl1-negative endothelial lineage.
Alternatively, the VSDs we observed may be a common
phenotype resulting from independent requirement for Jun in
Figure 7. Jun is efficiently deleted in Tie2-expressing endothelial derivatives. Cross sections of E15.5 Junflox/flox (A, K) and Tie2-Cre; Junflox/
flox (F, P) embryos co-immunostained with anti-CD31, anti-SMA and anti-Jun analyzed by confocal microscopy. Sections were co-stained with DAPI to
illustrate nuclei. (B–E, G–J) Higher power images of the areas indicated by white boxes in panels A, F. Smooth muscle cells (arrows) express Jun
(green) in control (E) and mutant embryos (J) whereas Jun is efficiently deleted in endothelial cells (arrowheads). (L–O, Q–T) Higher power images of
the area indicated by white boxes in panels K, P. Jun (red) is expressed in SMA-positive smooth muscle cells (green; arrows) in control (K) and mutant
embryos (P). Ao, aorta. Scale bar: 20 mm.
doi:10.1371/journal.pone.0057032.g007
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both Isl1-negative endothelial/endocardial cells and Tie2-negative
Isl1 progenitors.
Our finding of aortic arch artery patterning defects in Isl1-
specific Jun deleted embryos raises the possibility of a cell
autonomous effect of Jun in an Isl1-derived smooth muscle lineage
or alternatively a cell non-autonomous effect on another cell
population such as NC. There are other examples of genetic
alterations in the SHF affecting a tissue-tissue interaction with NC
cells. We have shown that deletion of Notch in the SHF using
Isl1Cre or Mef2c-AHF-Cre results in severe NC-related cardiac
defects including PTA and IAA [36], defects identical to those seen
in our Isl1Cre/+; Junflox/flox embryos and in Jun null embryos [5].
Further tissue-restricted deletion studies are required to determine
the relative requirement for Jun specifically in the smooth muscle
or myocardial lineages.
Our expression analysis indicates that Jun is expressed in post-
migratory NC derivatives. NC cells are a specialized subset of
neuroepithelial cells in the dorsal neural tube that migrate
ventrally and contribute to a diverse array of tissues. Raivich
et al. have previously reported that Jun is expressed in neuroep-
ithelial cells [68] yet deletion of Jun in neuroepithelial cells with
Nestin-Cre did not result in congenital heart defects [30,69]. It is
unclear if Nestin-Cre is expressed in a cardiac NC subset of
neuroepithelial cells. Cardiac NC cells, originating between the
mid-otic placode and the third somite, invade the pharyngeal
arches and encompass the aortic arch arteries around E10. By
E10.5 they populate the cardiac OFT as two columns of cells
subsequently forming a portion of the mesenchymal tissue in the
OFT endocardial cushions. Notably, these cushions are abnormal
in Jun null embryos [5]. Ultimately, descendants of this subset of
NC cells contribute to the aorticopulmonary septum, dividing the
truncus arteriosus into the aorta and pulmonary artery [10,70,71].
Although there is evidence that the complete loss of Jun does not
globally affect the fate of NC cells, by E12.5 there are fewer
Figure 8. Tie2-specific deletion of Jun results in cardiovascular defects. Compared to control embryos (B, D), the loss of Jun in Tie2-
expressing precursors results in VSD (open arrowhead, A), thinned RV (arrows, A) and thickened and hyperplastic mitral valve (closed arrowhead, A)
and pulmonary valve leaflets (open arrowhead, C). Ao, aorta; PA, pulmonary artery; RV, right ventricle.
doi:10.1371/journal.pone.0057032.g008
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connexin43-labeled cardiac NC cells populating the right ventric-
ular OFT of Jun null embryos [5]. In contrast, our findings suggest
that the defects observed in Isl1 and Tie2 conditional Jun mutant
embryos are not attributable to a cell non-autonomous defect of
cardiac NC migration. In the global Jun null embryo, it is
unknown whether the fewer connexin43-labeled cells is due to a
secondary cell non-autonomous mechanism affecting NC as the
result of a loss of Jun function in another tissue such as SHF or
pharyngeal endoderm. This is further complicated by the recent
observation that some Isl1-expressing progenitor cells may be of a
NC lineage [62]. This novel and surprising data raises the
possibility that the defects observed in Isl1-conditional Jun mutants
may reflect a cell autonomous defect of NC. The effect of
conditional deletion of Jun in Isl1-expressing progenitors on NC
cell differentiation was not determined in the current study but is
an important area for future investigation. Tissue-restricted
deletion studies using Wnt1-Cre or Pax3Cre/+ mice [72,73] are
required to determine the requirement for Jun specifically in NC
derivatives.
Jun, as part of the AP-1 transcription factor complex, is a
positive regulator of cell proliferation [7,8,32] and positively
regulates cell cycle progression through p19, p53, cyclin D1 and
cyclin A pathways [6,8,29,74,75,76,77]. It regulates the differen-
tiation of varied cell populations such as hematopoietic cells and
keratinocytes [6,9] and has also been shown to regulate apoptosis
in such cells as fibroblasts, hepatocytes and neurons [6,8,78,79].
Although these pleiotropic cellular functions are likely to be
important for all progenitors, our observation that Isl1- and Tie2-
specific Jun knockouts survive embryogenesis in Mendelian ratios
indicates that Jun is dispensable in these progenitors for overall
embryonic survival. Though Jun is not required for formation or
maintenance of the blood vessels (at least after the time of Tie2-
Cre-mediated recombination), it is not completely dispensable in
endothelial precursors as they display a low incidence of cardiac
defects. Out data do not exclude the possibility of subtle defects in
endothelial cell function in these Jun mutant embryos.
The molecular mechanisms by which Jun functions during heart
development, in Isl1-expressing cells and other cells remains to be
determined. In the embryonic human heart, ISL1 is strongly
expressed in highly proliferative SHF-derived cell populations in
the arterial and venous poles [80]. We observed a statistically
insignificant trend toward a decrease in proliferating cells and an
increase in apoptosis in the OFT of mutant embryos. These
individual differences were modest when compared with controls,
but in combination these two alterations may contribute to defects
in OFT septation or complete formation of the ventricular septum.
There are several transcriptional networks and signaling pathways
known to regulate proliferation in the SHF. These include Nkx2.5,
Wnt/ß-catenin, Notch, Fgf, Shh, Isl1, and Tbx1 signaling
pathways (reviewed in [13]). TBX1 is a molecular marker of the
SHF and accruing evidence points to a causative role for this
transcription factor in the pathogenesis of DiGeorge syndrome
(DGS). It has been proposed that the loss of TBX1 in patients with
DGS results in defective proliferation in the SHF [81,82],
although little mechanistic data have yet been published to
support this notion. Cardiac defects observed in patients with DGS
and in Tbx1 mutant mice are strikingly similar to those seen in Jun
mutant mouse embryos [83,84,85] and to mice in which NC has
been disrupted [10]. Despite the similarity with NC mutants and
reports of a disruption in the distribution of NC-derived cells in
Tbx1 nulls, Tbx1 is not expressed in NC [86]. One hypothesis is
that Jun and Tbx1 could be acting in concert to regulate the
proliferation of SHF progenitors and subsequently affect interac-
tions with other tissues such as NC. Future studies are required to
determine if Jun may function in a Tbx1-dependent pathway and
to further elucidate cell autonomous and cell non-autonomous
mechanisms of Jun function during heart development.
Materials and Methods
Ethics Statement
Animal studies were conducted in accordance with the National
Institutes of Health National Research Council Guide for the Care
and Use of Laboratory Animals and were approved by the
Children’s Hospital of Philadelphia Research Institute Institutional
Animal Care and Use Committee (No. 2008-6-840; Department
of Health and Human Services Animal Welfare Assurance
#A3442-01).
X-Gal Staining
Whole mount embryos were stained for ß-galactosidase activity
using previously described methods [87].
Confocal Microscopy
Confocal images were acquired with the Zeiss LSM 510/NLO
META confocal microscope using 20x, 0.8 NA Plan-Apochromat
air immersion and 63x, 1.4 NA Plan-Apochromat oil immersion
objectives.
Mutant Mice and Genotyping
All mouse strains used are previously described and listed here:
Junflox/flox is Juntm4Wag [7], Isl1Cre/+ is Isl1tm1(cre)Sev [25], Tie2-Cre is
Tg(Tek-cre)1Ywa [41], R26R is Gt(ROSA)26Sortm1Sor [40], mT/
mG is Gt(ROSA)26Sortm4(ACTB2tdTomato,2EGFP)Luo [34], and Jun+/2 is
Juntm1Pa [4]. The last four lines were obtained from the Jackson
Laboratory (Bar Harbor, ME). Mouse genotyping was performed
using real-time quantitative polymerase chain reaction (qPCR)
techniques. Genomic DNA was isolated with the Extract-N-Amp
Tissue PCR kit (Sigma-Aldrich, St. Louis, MO) according to the
manufacturer’s recommended protocol. PrimeTime qPCR assays
(Integrated DNA Technologies, Coralville, IA) consisting of the
primer and probe sequences listed in Table S1 were used. The
mouse GAPD TaqMan Gene Expression Assay (Life Technolo-
gies, Carlsbad, CA) was used as the endogenous control.
Immunohistochemistry
Immunofluorescence (IF) and horseradish peroxidase (HRP)
immunostaining were performed as described previously [88]
using rabbit monoclonal anti-Jun 60A8 (1:100 IF; Cell Signaling
Technology, Danvers, MA), rat monoclonal anti-CD31 MEC13.3
(Pecam1; 1:100; BD Pharmingen, Franklin Lakes, NJ), mouse
monoclonal anti-Isl-1 39.4D5 (1:25 IF; Developmental Studies
Hybridoma Bank, Iowa City, IA), rabbit polyclonal anti-GFP
(1:200 IF, Life Technologies), mouse monoclonal anti-SMA 1A4
(1:200 IF, Life Technologies), rabbit polyclonal phospho-histone
H3 Ser10 (1:200 IF, Cell Signaling Technology), mouse mono-
clonal AP-2 alpha (Tfap2a) 3B5 (1:4 IF, Developmental Studies
Hybridoma Bank) and mouse monoclonal NFATc1 7A6 (1:25 IF,
Developmental Studies Hybridoma Bank). TUNEL assays were
performed using the In Situ Cell Death Detection Kit (Roche,
Indianapolis, IN) according to the manufacturer’s recommended
protocol. Images were quantified by using the Image-based Tool
for Counting Nuclei (ITCN) plug-in (http://goo.gl/fPQ6B) for
ImageJ (NIH, Bethesda, MD). The mean and SEM were
calculated based on three independent sections per embryo.
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Whole Mount in situ Hybridization
Whole mount in situ hybridization was performed as described
[89] with modifications. Digoxigenin-UTP-labeled RNA probes
were generated from plasmid template containing mouse Jun
(IMAGE clone 3493248; GenBank accession number BC002081)
by XmaI restriction digestion and transcription with T7 RNA
polymerase. Embryos were fixed in 4% PFA overnight, then
dehydrated in a graded series of methanol in PBST. The embryos
were serially rehydrated to PBST. Embryos were permeabilized in
RIPA buffer thrice for 5 minutes at room temperature. Embryos
were refixed in 4% PFA/0.2% glutaraldehyde in PBS for 20
minutes, washed and hybridized overnight at 70uC in hybridiza-
tion solution containing 1 mg probe/mL. Embryos were washed
and hybridized with alkaline phosphatase conjugated anti-digox-
igenin antibody (Roche) overnight at 4uC, washed for 24 hours
and developed in BM purple (Roche).
Supporting Information
Figure S1 Jun is broadly expressed in the late gestation
mouse heart. (A, E) Transverse sections of an E15.5 wild-type
mouse heart showing nuclear Jun immunostaining (green) in the
myocardium and valves. (B–D) Higher power images of the areas
shown in the white boxes in panel A showing Jun expression in the
myocardium and atrioventricular valves. (F) Higher power image
of the area shown in the white box in panel E showing Jun
expression in the right ventricular outflow tract myocardium and
pulmonary valve. Sections were co-stained with DAPI to illustrate
nuclei. Ao, aorta; IVS, interventricular septum; LA, left atrium;
LV, left ventricle; MV, mitral valve; PA, pulmonary artery; PV,
pulmonary valve; RA, right atrium; RV, right ventricle; TV,
tricuspid valve.
(TIF)
Table S1 qPCR Genotyping Assays. Primer and probe
sequences used for mouse genotyping. Mouse GAPD was used as
the endogenous control.
(DOC)
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